{"product_id":"biolegend-400908","title":"Biolegend, 400908, PE Armenian Hamster IgG Isotype Ctrl Antibody, 100μg","description":"\u003cp\u003eThis antibody was chosen as an isotype control after screening on a variety of resting, activated, live, and fixed mouse, rat and human tissues.\u003cbr\u003e\n100μg\u003cbr\u003e\nAntibody Type: Monoclonal\u003cbr\u003e\nHost Species: Armenian Hamster\u003cbr\u003e\nImmunogen: Trinitrophenol + KLH\u003cbr\u003e\nFormulation: Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.\u003cbr\u003e\nPreparation: The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.\u003cbr\u003e\nConcentration: 0.2 mg\/ml\u003cbr\u003e\nStorage \u0026amp; Handling: The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.\u003cbr\u003e\nApplication: FC - Quality tested ICFC - Verified\u003cbr\u003e\nRecommended Usage: Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis as negative control. Use at concentrations comparable to those of the specific antibody of interest.\u003cbr\u003e\nExcitation Laser: Blue Laser (488 nm)Green Laser (532 nm)\/Yellow-Green Laser (561 nm)\u003cbr\u003e\nApplication Notes: Additional reported applications (for the relevant formats) include: Intracellular Flow Cytometry (ICFC), Immunocytochemistry (ICC), Immunohistochemistry (IHC), Immunoprecipitation (IP), Western Blotting (WB), Functional Assay (FA)For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Cat. No. 400940) with a lower endotoxin limit (Endotoxin \u0026lt; 0.01 EU\/µg).\u003cbr\u003e\nApplication References(PubMed link indicates BioLegend citation): Lesley R, et al. 2006. P. Natl. Acad. Sci. USA 103:10717. Yu R, et al. 2006. Obesity 14:1353. Yang JH, et al.2005. Rheumatology(Oxford). 44:1245. PubMed Mina-Osorio P, et al. 2008. J. Leukocyte Biol. 84:448. PubMed Shen H, et al. 2009. J. Am Soc Nephrol. 20:1032. PubMed\u003cbr\u003e\nProduct Citations: Hou X, et al. 2020. Cell Reports. 28(1):172-189.e7.. PubMed Jayachandran R, et al. 2019. Immunity. 50:152. PubMed Zhang W, et al. 2023. Front Pharmacol. 14:1092767. PubMed Kaltenbach L, et al. 2023. Nat Immunol. 24:915. PubMed Jiao Q, et al. 2020. Br J Dermatol. 182:648. PubMed Ocaña-Guzman R, et al. 2022. Cells. 11: . PubMed Gon Y, et al. 2023. PLoS One. 18:e0279389. PubMed Zenke S, et al. 2022. Nat Commun. 13:6459. PubMed Chamoto K, et al. 2013. Stem Cell Res. 10:267. PubMed Poh AR, et al. 2017. Cancer Cell. 31:563. PubMed Postat J et al. 2018. Immunity. 49(4):654-665 . PubMed de Tymowski C et al. 2019. Cell reports. 27(3):762-775 . PubMed Wei H, et al. 2021. Malar J. 20:89. PubMed Hirano KI, et al. 2021. eLife. 0.416666666666667. PubMed Fan C, et al. 2020. Stem Cell Res Ther. 0.765277778. PubMed Wu R, et al. 2019. J Cell Mol Med. 24:1684. PubMed Weckbach L, et al. 2014. Blood. 123:1887. PubMed Lan WR, et al. 2019. Stem Cells Int. 2019:8404168. PubMed Rohrschneider L 2010. Genes Dev. 24:1882. PubMed Hasezaki T, et al. 2020. Sci Rep. 10:6969. PubMed Zhuang Z, et al. 2021. J Exp Med. 218:00:00. PubMed Akram KM, et al. 2019. Nat Commun. 10:1178. PubMed Su W, et al. 2022. Front Immunol. 13:952338. PubMed Akagi T, et al. 2022. Front Immunol. 13:926175. PubMed Tang S, et al. 2021. Front Cell Dev Biol. 9:670913. PubMed Tuttle KD, et al. 2020. Cell Rep. 33:108407. PubMed Wei SC, et al. 2020. Cancer Discov. . PubMed He W et al. 2018. Immunity. 49(6):1175-1190 . PubMed Pein M, et al. 2020. Nat Commun. 11:1494. PubMed Paterson N, et al. 2022. Elife. 11:. PubMed West A, et al. 2016. Oncogenesis . 5: e216. PubMed Fulham MA, et al. 2019. Am J Physiol Cell Physiol. 317:C687. PubMed Kang SJ, et al. 2022. Food Sci Anim Resour. 42:903. PubMed Leitner J, et al. 2015. J Immunol. 195: 477 - 487. PubMed Jain P, et al. 2010. J Immunol. 184:7196. PubMed Nizri E, et al. 2009. J Immunol. 183:6681. PubMed Abe M, et al. 2020. Clin Exp Immunol. 303:199. PubMed Madenspacher JH, et al. 2020. JCI Insight. 5:00. PubMed López MJ, et al. 2018. Invest Ophthalmol Vis Sci. 59:5671. PubMed Li J, et al. 2022. Nat Commun. 13:4032. PubMed Shibuya M, et al. 2021. iScience. 24:103131. PubMed Deng P, et al. 2021. Cell Stem Cell. 28(6):1057-1073.e7. PubMed Meunier I, et al. 2015. PLoS One. 10: 0138055. PubMed Santini MP, et al. 2020. Cell Rep. 30:555. PubMed Molina MS, et al. 2021. Front Immunol. 12:699128. PubMed Lai JH, et al. 2021. iScience. 24(6):102498. PubMed Yang C, et al. 2019. J Transl Med. 1.004166667. PubMed Pele T, et al. 2021. Int J Mol Sci. 22:. PubMed Gross KM, et al. 2019. Cell Rep. 28:394. PubMed Koyama M et al. 2019. Immunity. 51(5):885-898 . PubMed Hong Y, et al. 2019. J Extracell Vesicles. 8:1670893. PubMed Akhtar MN, et al. 2020. PLoS Pathog. 16:e1009136. PubMed Lin YC, et al. 2020. Mol Med Rep. 22:4909. PubMed\u003cbr\u003e\nRRID: AB_326593 (BioLegend Cat. No. 400907) AB_326593 (BioLegend Cat. No. 400908)\u003cbr\u003e\nGene ID: NA\u003cbr\u003e\nClone: HTK888\u003cbr\u003e\nRegulatory Status: RUO\u003cbr\u003e\nIsotype: Armenian Hamster IgG\u003cbr\u003e\nQ: What type of PE do you use in your conjugates?\u003cbr\u003e\nA: We use R-PE in our conjugates.\u003c\/p\u003e","brand":"Biolegend","offers":[{"title":"Default Title","offer_id":46866102780073,"sku":"400908","price":0.99,"currency_code":"USD","in_stock":true}],"url":"https:\/\/iright.com\/products\/biolegend-400908","provider":"Iright","version":"1.0","type":"link"}